Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.
Debbie Law received a D. Phil. in immunology from the University of Oxford in 1989 and held a post-doctoral position at the University of California, San Francisco from 1989 to 1995. Debbie has over thirteen years experience in the biotech industry. She started her career with Cor Therapeutics in 1995. She has held senior managerial and research roles in EOS Biotechnology. Prior to joining Ablynx, Debbie spent five years with PDL BioPharma where she since 2006 held the position of Vice President of Research. 
